Sort
48,018 grants matching “immunotherapy”
Development of a novel therapy targeting the tumor microenvironment in inflammatory breast cancer
$1,309,379Naoto T Ueno · University Of Hawaii At Manoa · R01 · FY2025 · CA
Center for Multiparametric Imaging of Tumor Immune Microenvironments
$1,309,112Paolo Provenzano · University Of Minnesota · U54 · FY2022 · CA
PEDIATRIC AIDS CLINICAL TRIALS PROGRAM
$1,308,707Baylor College Of Medicine · U01 · FY2000 · AI
Role of the microbiota in regulating the mononuclear phagocyte system
$1,307,792Romina Goldszmid · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Liver Cancer Program
$1,307,380Anuradha Budhu · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
SPORE IN OVARIAN CANCER
$1,306,011University Of Alabama At Birmingham · P50 · FY2004 · CA
Unraveling the Molecular Underpinnings of Premalignant Oral Lesion Transformation into Head and Neck Cancer
$1,305,876Joe Nguyen · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Epigenetic Therapy for Thoracic Malignancies
$1,305,530David Schrump · Division Of Clinical Sciences - Nci · ZIA · FY2025 · CA
Functional Genomics of Sarcoma
$1,305,399Paul S. Meltzer · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
A Phase II Trial of Rituximab In Myasthenia Gravis
$1,305,373Richard Nowak · Yale University · U01 · FY2013 · NS
Next generation T cell therapies for mutant KRAS solid tumors
$1,305,260Beatriz M. Carreno · University Of Pennsylvania · UG3 · FY2023 · CA
JOHNS HOPKINS ADULT AIDS CLINICAL TRIALS UNIT
$1,304,490Johns Hopkins University · U01 · FY2000 · AI
DEVELOPMENT OF GUAR-T AS A NOVEL CLASS OF UNIVERSAL CELLULAR IMMUNOTHERAPIES FOR OVARIAN CANCER
$1,304,470Yale Univ · · FY2025 · Defense Health Agency
IL-2 Family Cytokines and their Receptors-- Biology of the IL-2 system
$1,304,042Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
IL-2 Family Cytokines and Receptors-- Mechanisms of Regulation & Action
$1,304,042Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
Protein Expression Facility
$1,303,146Robert Petrovich · National Institute Of Environmental Health Sciences · ZIC · FY2024 · ES
GMP Production of a Human Monoclonal Antibody for the Treatment of HUS
$1,303,141Donna E Akiyoshi · Tufts University Boston · R56 · FY2010 · AI
Improving the efficacy of anti-nicotine immunotherapy
$1,303,043Alexey G Mukhin · Duke University · RC2 · FY2009 · DA
Building on the success of the adoptive immunotherapy of cancer
$1,302,115Nicholas Restifo · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Modulation of cancer induced immune suppression via inhibition of SCD1
$1,301,808Karen E Hayes · Modulation Therapeutics, Inc. · R44 · FY2023 · CA
Leveraging DNA damage repair pathways as therapeutic targets in womens cancers
$1,301,281Jung-Min Lee · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
INHIBITING MDSC BIOGENESIS TO AUGMENT IMMUNOTHERAPY EFFICACY IN TRIPLE-NEGATIVE BREAST CANCER
$1,301,250Health Research, Inc. · · FY2025 · Defense Health Agency
The Role of Protein Methylation in Squamous Cell Carcinoma of the Head and Neck
$1,300,908Vassiliki Saloura · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Investigating mechanisms of bladder tumorigenesis and therapeutic resistance
$1,300,700Abdul Banday · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Vaccine strategies for HIVAIDS
$1,300,408Jay A Berzofsky · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA